AAAAAA
Results: 1-25/40
Authors:
Davidovici, B
Karakis, I
Bourboulia, D
Ariad, S
Zong, JC
Benharroch, D
Dupin, N
Weiss, R
Hayward, G
Sarov, B
Boshoff, C
Citation: B. Davidovici et al., Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associatedherpesvirus among Jewish population groups in Israel, J NAT CANC, 93(3), 2001, pp. 194-202
Authors:
Boshoff, C
Weiss, RA
Citation: C. Boshoff et Ra. Weiss, Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus, PHI T ROY B, 356(1408), 2001, pp. 517-534
Authors:
Boshoff, C
Weiss, R
Citation: C. Boshoff et R. Weiss, Cancer processes in immunodeficient populations: an introduction, EUR J CANC, 37(10), 2001, pp. 1202-1208
Authors:
Gambus, G
Bourboulia, D
Esteve, A
Lahoz, R
Rodriguez, C
Bolao, F
Sirera, G
Muga, R
del Romero, J
Boshoff, C
Whitby, D
Casabona, J
Citation: G. Gambus et al., Prevalence and distribution of HHV-8 in different subpopulations, with andwithout HIV infection, in Spain, AIDS, 15(9), 2001, pp. 1167-1174
Authors:
Boshoff, C
Chang, Y
Citation: C. Boshoff et Y. Chang, Kaposi's sarcoma - Associated herpesvirus: A new DNA tumor virus, ANN R MED, 52, 2001, pp. 453-470
Authors:
Low, W
Harries, M
Ye, HT
Du, MQ
Boshoff, C
Collins, M
Citation: W. Low et al., Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, J VIROLOGY, 75(6), 2001, pp. 2938-2945
Authors:
Jenner, RG
Alba, MM
Boshoff, C
Kellam, P
Citation: Rg. Jenner et al., Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays, J VIROLOGY, 75(2), 2001, pp. 891-902
Authors:
Du, MQ
Liu, HX
Diss, TC
Ye, HT
Hamoudi, RA
Dupin, N
Meignin, V
Oksenhendler, E
Boshoff, C
Isaacson, PG
Citation: Mq. Du et al., Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders, BLOOD, 97(7), 2001, pp. 2130-2136
Authors:
Weiss, R
Boshoff, C
Citation: R. Weiss et C. Boshoff, Addressing controversies over Kaposi's sarcoma, J NAT CANC, 92(9), 2000, pp. 677-679
Authors:
Sharp, TV
Boshoff, C
Citation: Tv. Sharp et C. Boshoff, Kaposi's sarcoma-associated herpesvirus: From cell biology to pathogenesis, IUBMB LIFE, 49(2), 2000, pp. 97-104
Authors:
Radkov, SA
Kellam, P
Boshoff, C
Citation: Sa. Radkov et al., The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells, NAT MED, 6(10), 2000, pp. 1121-1127
Authors:
Mittnacht, S
Boshoff, C
Citation: S. Mittnacht et C. Boshoff, Viral cyclins, REV MED VIR, 10(3), 2000, pp. 175-184
Authors:
Boshoff, C
Mels, G
Citation: C. Boshoff et G. Mels, The impact of multiple commitments on intentions to resign: an empirical assessment, BR J MANAGE, 11(3), 2000, pp. 255-272
Authors:
Boshoff, C
Allen, J
Citation: C. Boshoff et J. Allen, The influence of selected antecedents on frontline staff's perceptions of service recovery performance, INT J S IND, 11(1), 2000, pp. 63-90
Authors:
Codish, S
Abu-Shakra, M
Ariad, S
Zirkin, HJ
Yermiyahu, T
Dupin, N
Boshoff, C
Sukenik, S
Citation: S. Codish et al., Manifestations of three HHV-8-related diseases in an HIV-negative patient:Immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma, AM J HEMAT, 65(4), 2000, pp. 310-314
Authors:
Zago, A
Bourboulia, D
Viana, MC
Collandre, H
Dietze, R
Boshoff, C
Keller, R
Citation: A. Zago et al., Seroprevalence of human herpesvirus 8 and its association with Kaposi sarcoma in Brazil, SEX TRA DIS, 27(8), 2000, pp. 468-472
Authors:
Eisen, T
Boshoff, C
Mak, I
Sapunar, F
Vaughan, MM
Pyle, L
Johnston, SRD
Ahern, R
Smith, IE
Gore, ME
Citation: T. Eisen et al., Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer, BR J CANC, 82(4), 2000, pp. 812-817
Authors:
Whitby, D
Luppi, M
Sabin, C
Barozzi, P
Di Biase, AR
Balli, F
Cucci, F
Weiss, RA
Boshoff, C
Torelli, G
Citation: D. Whitby et al., Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission, BR J CANC, 82(3), 2000, pp. 702-704
Authors:
Stine, JT
Wood, C
Hill, M
Epp, A
Raport, CJ
Schweickart, VL
Endo, Y
Sasaki, T
Simmons, G
Boshoff, C
Clapham, P
Chang, Y
Moore, P
Gray, PW
Chantry, D
Citation: Jt. Stine et al., KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells, BLOOD, 95(4), 2000, pp. 1151-1157
Authors:
Dupin, N
Diss, TL
Kellam, P
Tulliez, M
Du, MQ
Sicard, D
Weiss, RA
Isaacson, PG
Boshoff, C
Citation: N. Dupin et al., HHV-8 is associated with a plasmablastic variant of Castleman disease thatis linked to HHV-8-positive plasmablastic lymphoma, BLOOD, 95(4), 2000, pp. 1406-1412
Authors:
Ariad, S
Benharroch, D
Lupu, L
Davidovici, B
Dupin, N
Boshoff, C
Citation: S. Ariad et al., Early peripheral lymph node involvement of human herpesvirus 8-associated,body cavity-based lymphoma in a human immunodeficiency virus-negative patient, ARCH PATH L, 124(5), 2000, pp. 753-755
Authors:
Boshoff, C
Citation: C. Boshoff, Kaposi's sarcoma and other HHV-8 associated tumors, INFEC DIS S, 2000, pp. 161-194
Authors:
Boshoff, C
Citation: C. Boshoff, Human herpesvirus-8 encoded chemokines, EUR CYTOKIN, 10(2), 1999, pp. 292-295
Authors:
Boshoff, C
Weiss, RA
Citation: C. Boshoff et Ra. Weiss, HHV8/KSHV - Introduction, SEM CANC B, 9(3), 1999, pp. 149-150
Authors:
Ellis, M
Chew, YP
Fallis, L
Freddersdorf, S
Boshoff, C
Weiss, RA
Lu, X
Mittnacht, S
Citation: M. Ellis et al., Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex, EMBO J, 18(3), 1999, pp. 644-653